PAH Sisters' Journey to Diagnosis and Hope
· news
The Rare Disease That Binds Sisters Together
Megan Kaverman and her sister Katie Gusching have been on a journey of misdiagnosis, perseverance, and hope after both were diagnosed with heritable pulmonary arterial hypertension (PAH), a rare genetic disorder that affects the small arteries in the lungs.
Their experiences highlight the flaws in our healthcare system. Megan’s struggles to find answers for years, being dismissed by doctors as “too young” to have a heart problem, demonstrate ageism and medical complacency. Her determination to seek a diagnosis, despite being met with skepticism and dismissal, is a testament to her strength and resilience.
Katie eventually showed symptoms of the same disease after years of Megan’s advocacy and education, emphasizing the importance of awareness and early detection. According to Orphanet, fewer than one in 1 million people are diagnosed with PAH, and most patients are diagnosed when they are already in heart failure.
The heritable version of PAH is a genetic disorder that affects a small percentage of the population but has a devastating impact on families. The disease has no cure, but with proper treatment and management, patients can lead relatively normal lives. Megan credits her treatment at the Cleveland Clinic for giving her a “second life.”
Megan’s case also highlights the importance of access to quality care. Her sister Katie was diagnosed after years of advocacy from Megan, who hopes that by sharing their story, they can educate others about PAH and encourage early detection. As Megan said, “If I save one person’s life by bringing awareness, I’ve done my job.”
The Cleveland Clinic is also working on developing new treatments for PAH. Dr. Kristen Highland notes the growing hope for patients, a welcome respite from the usual medical headlines. The clinic’s participation in clinical trials aimed at creating new care options is a promising development that could potentially change the lives of thousands.
In the midst of their struggles, one bright spot shines through: their bond has grown stronger as they navigate this challenging journey together. By facing their fears and advocating for each other, Megan and Katie have found comfort in their shared experience.
Their story serves as a reminder of the importance of awareness, advocacy, and access to quality care. It’s clear that PAH is not just a medical condition – it’s a family affair. The sisters’ experiences are a testament to the human spirit’s capacity for resilience, hope, and love.
As Megan and Katie continue their treatment plans, they do so with a newfound appreciation for life and each other. They are not just patients – they are sisters, advocates, and champions of awareness. Their story will undoubtedly inspire others to join them in this fight against PAH and to cherish the relationships that bind us together.
Their bond has grown stronger through their shared experience, and Megan says, “This brings us closer together.”
Reader Views
- EKEditor K. Wells · editor
One glaring omission from this article is the financial burden that patients with PAH face. While treatment can grant a relatively normal life, the cost of medications and hospital stays can be prohibitively expensive for many families. Megan's success at the Cleveland Clinic was undoubtedly due in part to her access to quality care, but what about those who don't have that luxury? Without addressing the systemic issue of medical costs, we're only scratching the surface of a complex problem.
- RJReporter J. Avery · staff reporter
One of the most disturbing aspects of Megan and Katie's story is not just the diagnostic delay, but also the potential long-term consequences for their family. Heritable PAH is a genetic disorder that can be passed down to future generations, meaning every sibling, child, or parent may be at risk. It's alarming to think about how many families are unaware of this risk, and how Megan's experience could repeat itself in other households. A thorough examination of the implications of hereditary diseases on family dynamics is long overdue.
- ADAnalyst D. Park · policy analyst
The Kaverman sisters' harrowing journey to diagnosis with heritable PAH underscores the dire need for earlier detection and targeted care. What's striking is how their experience mirrors that of countless others living with rare diseases: dismissed by clinicians, left to navigate labyrinthine healthcare systems on their own. It's essential to recognize that awareness campaigns can only do so much; systemic reform is needed to ensure timely diagnosis and equitable access to cutting-edge treatments.